Download PDF
Semin Liver Dis 2008; 28(3): 282-292
DOI: 10.1055/s-0028-1085096
© Thieme Medical Publishers

Extrahepatic Portal Vein Thrombosis

Juan Carlos Garcia-Pagán1 , Manuel Hernández-Guerra2 , Jaime Bosch1
  • 1Hepatic Hemodynamic Laboratory, Liver Unit, IMDIM, Hospital Clínic, IDIBAPS and Ciberehd, Barcelona, Spain
  • 2Department of Gastroenterology, University Hospital of the Canary Islands, La Laguna, Santa Cruz de Tenerife, Spain
Further Information

Publication History

Publication Date:
23 September 2008 (online)

    Permissions and Reprints

ABSTRACT

Noncirrhotic, nontumoral portal vein thrombosis (PVT) is the second most-frequent cause of portal hypertension in the world. General thrombophilic factors can be identified in approximately 60% of patients. PVT may manifest as an acute process. However, the acute episode more frequently is asymptomatic or paucisymptomatic and portal vein thrombosis is misdiagnosed until the development of complications secondary to portal hypertension, such as variceal bleeding or portal biliopathy. Although no randomized controlled trials have been performed, after the diagnosis of acute PVT early initiation of anticoagulation (within 30 days of the onset of symptoms) is recommended to achieve recanalization. In patients with portal cavernoma, anticoagulation is aimed to prevent the progression and recurrence of thrombosis. Because of the lack of data in this specific population, variceal bleeding is managed as in cirrhotic patients. Ursodeoxycholic acid has been proposed empirically for the treatment of patients with symptomatic portal biliopathy. Choledocholithiasis might be present, complicating a bile duct stenosis. Accordingly, an endoscopic retrograde cholangiopancreatography with sphincterotomy, extraction with balloon catheter, and stent placement is indicated. Mortality among patients with PVT is low (5-year mortality rate of 5 to 10%) and is mainly related to associated diseases rather than to complications of portal hypertension.

KEYWORDS

Portal hypertension - thrombophilia - cholangiopathy

REFERENCES

  • 1 Valla D C, Condat B. Portal vein thrombosis in adults: pathophysiology, pathogenesis and management.  J Hepatol. 2000;  32(5) 865-871
    CrossrefPubMedGoogle Scholar
  • 2 Sarin S K, Agarwal S R. Extrahepatic portal vein obstruction.  Semin Liver Dis. 2002;  22(1) 43-58
    Article in Thieme ConnectPubMedGoogle Scholar
  • 3 Valla D C, Condat B, Lebrec D. Spectrum of portal vein thrombosis in the West.  J Gastroenterol Hepatol. 2002;  17(Suppl 3) S224-S227
    CrossrefPubMedGoogle Scholar
  • 4 Sarin S K, Sollano J D, Chawla Y K et al.. Consensus on extra-hepatic portal vein obstruction.  Liver Int. 2006;  26(5) 512-519
    CrossrefPubMedGoogle Scholar
  • 5 Denninger M H, Chait Y, Casadevall N et al.. Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors.  Hepatology. 2000;  31(3) 587-591
    CrossrefPubMedGoogle Scholar
  • 6 Janssen H L, Meinardi J R, Vleggaar F P et al.. Factor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis: results of a case-control study.  Blood. 2000;  96(7) 2364-2368
    PubMedGoogle Scholar
  • 7 Bombeli T, Basic A, Fehr J. Prevalence of hereditary thrombophilia in patients with thrombosis in different venous systems.  Am J Hematol. 2002;  70(2) 126-132
    CrossrefPubMedGoogle Scholar
  • 8 Bhattacharyya M, Makharia G, Kannan M, Ahmed R P, Gupta P K, Saxena R. Inherited prothrombotic defects in Budd-Chiari syndrome and portal vein thrombosis: a study from North India.  Am J Clin Pathol. 2004;  121(6) 844-847
    CrossrefPubMedGoogle Scholar
  • 9 Primignani M, Martinelli I, Bucciarelli P et al.. Risk factors for thrombophilia in extrahepatic portal vein obstruction.  Hepatology. 2005;  41(3) 603-608
    CrossrefPubMedGoogle Scholar
  • 10 Turnes J, Garcia-Pagan J C, Gonzalez M et al.. Portal hypertensive complications after acute portal vein thrombosis: impact of early anticoagulation.  Clin Gastroenterol Hepatol. 2008;  , In press
    PubMedGoogle Scholar
  • 11 Plessier A, Murad S D, Hernandez-Guerra M et al.. A prospective multicentric follow-up study on 105 patients with acute portal vein thrombosis (PVT): results from the European Network for Vascular Disorders of the Liver (EN-VIE).  Hepatology. 2007;  46(suppl 1) 310A
    PubMedGoogle Scholar
  • 12 Rosendaal F R. Venous thrombosis: a multicausal disease.  Lancet. 1999;  353(9159) 1167-1173
    CrossrefPubMedGoogle Scholar
  • 13 Janssen H L, Wijnhoud A, Haagsma E B et al.. Extrahepatic portal vein thrombosis: aetiology and determinants of survival.  Gut. 2001;  49(5) 720-724
    CrossrefPubMedGoogle Scholar
  • 14 de Franchis R. Evolving Consensus in Portal Hypertension Report of the Baveno IV Consensus Workshop on Methodology of Diagnosis and Therapy in Portal Hypertension.  J Hepatol. 2005;  43(1) 167-176
    CrossrefPubMedGoogle Scholar
  • 15 Valla D, Casadevall N, Huisse M G et al.. Etiology of portal vein thrombosis in adults. A prospective evaluation of primary myeloproliferative disorders.  Gastroenterology. 1988;  94(4) 1063-1069
    PubMedGoogle Scholar
  • 16 Denninger M H, Helley D, Valla D, Guillin M C. Prospective evaluation of the prevalence of factor V Leiden mutation in portal or hepatic vein thrombosis.  Thromb Haemost. 1997;  78(4) 1297-1298
    PubMedGoogle Scholar
  • 17 De Stefano V, Teofili L, Leone G, Michiels J J. Spontaneous erythroid colony formation as the clue to an underlying myeloproliferative disorder in patients with Budd-Chiari syndrome or portal vein thrombosis.  Semin Thromb Hemost. 1997;  23(5) 411-418
    Article in Thieme ConnectPubMedGoogle Scholar
  • 18 Chait Y, Condat B, Cazals-Hatem D et al.. Relevance of the criteria commonly used to diagnose myeloproliferative disorder in patients with splanchnic vein thrombosis.  Br J Haematol. 2005;  129(4) 553-560
    CrossrefPubMedGoogle Scholar
  • 19 Kralovics R, Passamonti F, Buser A S et al.. A gain-of-function mutation of JAK2 in myeloproliferative disorders.  N Engl J Med. 2005;  352(17) 1779-1790
    CrossrefPubMedGoogle Scholar
  • 20 James C, Ugo V, Le Couedic J P et al.. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera.  Nature. 2005;  434(7037) 1144-1148
    CrossrefPubMedGoogle Scholar
  • 21 Jones A V, Kreil S, Zoi K et al.. Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders.  Blood. 2005;  106(6) 2162-2168
    CrossrefPubMedGoogle Scholar
  • 22 Baxter E J, Scott L M, Campbell P J et al.. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders.  Lancet. 2005;  365(9464) 1054-1061
    CrossrefPubMedGoogle Scholar
  • 23 Primignani M, Barosi G, Bergamaschi G et al.. Role of the JAK2 mutation in the diagnosis of chronic myeloproliferative disorders in splanchnic vein thrombosis.  Hepatology. 2006;  44(6) 1528-1534
    CrossrefPubMedGoogle Scholar
  • 24 Colaizzo D, Amitrano L, Tiscia G L et al.. The JAK2 V617F mutation frequently occurs in patients with portal and mesenteric venous thrombosis.  J Thromb Haemost. 2007;  5(1) 55-61
    PubMedGoogle Scholar
  • 25 Kiladjian J J, Cervantes F, Leebeek F W et al.. The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis. A report on 241 cases.  Blood. 2008;  11(10) 4922-4929
    PubMedGoogle Scholar
  • 26 Patel R K, Lea N C, Heneghan M A et al.. Prevalence of the activating JAK2 tyrosine kinase mutation V617F in the Budd-Chiari syndrome.  Gastroenterology. 2006;  130(7) 2031-2038
    CrossrefPubMedGoogle Scholar
  • 27 Tefferi A, Thiele J, Orazi A et al.. Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel.  Blood. 2007;  110(4) 1092-1097
    CrossrefPubMedGoogle Scholar
  • 28 Robson S C, Kahn D, Kruskal J, Bird A R, Kirsch R E. Disordered hemostasis in extrahepatic portal hypertension.  Hepatology. 1993;  18(4) 853-857
    CrossrefPubMedGoogle Scholar
  • 29 Fisher N C, Wilde J T, Roper J, Elias E. Deficiency of natural anticoagulant proteins C, S, and antithrombin in portal vein thrombosis: a secondary phenomenon?.  Gut. 2000;  46(4) 534-539
    CrossrefPubMedGoogle Scholar
  • 30 de Bruijne E L, Murad S D, de Maat M P et al.. Genetic variation in thrombin-activatable fibrinolysis inhibitor (TAFI) is associated with the risk of splanchnic vein thrombosis.  Thromb Haemost. 2007;  97(2) 181-185
    PubMedGoogle Scholar
  • 31 Bernades P, Baetz A, Levy P, Belghiti J, Menu Y, Fekete F. Splenic and portal venous obstruction in chronic pancreatitis. A prospective longitudinal study of a medical-surgical series of 266 patients.  Dig Dis Sci. 1992;  37(3) 340-346
    CrossrefPubMedGoogle Scholar
  • 32 Fujita F, Lyass S, Otsuka K et al.. Portal vein thrombosis following splenectomy: identification of risk factors.  Am Surg. 2003;  69(11) 951-956
    PubMedGoogle Scholar
  • 33 Bick R L. Coagulation abnormalities in malignancy: a review.  Semin Thromb Hemost. 1992;  18(4) 353-372
    Article in Thieme ConnectPubMedGoogle Scholar
  • 34 Shaldon S, Sherlock S. Obstruction to the extrahepatic portal system in childhood.  Lancet. 1962;  1 63-68
    PubMedGoogle Scholar
  • 35 Webb L J, Sherlock S. The aetiology, presentation and natural history of extra-hepatic portal venous obstruction.  Q J Med. 1979;  48(192) 627-639
    PubMedGoogle Scholar
  • 36 Pinto R B, Silveira T R, Bandinelli E, Rohsig L. Portal vein thrombosis in children and adolescents: the low prevalence of hereditary thrombophilic disorders.  J Pediatr Surg. 2004;  39(9) 1356-1361
    CrossrefPubMedGoogle Scholar
  • 37 Langnas A N, Marujo W, Stratta R J, Wood R P, Shaw Jr B W. Vascular complications after orthotopic liver transplantation.  Am J Surg. 1991;  161(1) 76-82
    Google Scholar
  • 38 Cazals-Hatem D, Vilgrain V, Genin P et al.. Arterial and portal circulation and parenchymal changes in Budd-Chiari syndrome: a study in 17 explanted livers.  Hepatology. 2003;  37(3) 510-519
    CrossrefPubMedGoogle Scholar
  • 39 Murad S D, Valla D C, de Groen P C et al.. Pathogenesis and treatment of Budd-Chiari syndrome combined with portal vein thrombosis.  Am J Gastroenterol. 2006;  101(1) 83-90
    CrossrefPubMedGoogle Scholar
  • 40 Van Gansbeke D, Avni E F, Delcour C, Engelholm L, Struyven J. Sonographic features of portal vein thrombosis.  AJR Am J Roentgenol. 1985;  144(4) 749-752
    PubMedGoogle Scholar
  • 41 Gebel M, Caselitz M, Bowen-Davies P E, Weber S. A multicenter, prospective, open label, randomized, controlled phase IIIb study of SH U 508 a (Levovist) for Doppler signal enhancement in the portal vascular system.  Ultraschall Med. 1998;  19(4) 148-156
    Article in Thieme ConnectPubMedGoogle Scholar
  • 42 Rossi S, Rosa L, Ravetta V et al.. Contrast-enhanced versus conventional and color Doppler sonography for the detection of thrombosis of the portal and hepatic venous systems.  AJR Am J Roentgenol. 2006;  186(3) 763-773
    CrossrefPubMedGoogle Scholar
  • 43 Marshall M M, Beese R C, Muiesan P, Sarma D I, O'Grady J, Sidhu P S. Assessment of portal venous system patency in the liver transplant candidate: a prospective study comparing ultrasound, microbubble-enhanced colour Doppler ultrasound, with arteriography and surgery.  Clin Radiol. 2002;  57(5) 377-383
    CrossrefPubMedGoogle Scholar
  • 44 Mathieu D, Vasile N, Grenier P. Portal thrombosis: dynamic CT features and course.  Radiology. 1985;  154(3) 737-741
    PubMedGoogle Scholar
  • 45 Mori H, Hayashi K, Uetani M, Matsuoka Y, Iwao M, Maeda H. High-attenuation recent thrombus of the portal vein: CT demonstration and clinical significance.  Radiology. 1987;  163(2) 353-356
    PubMedGoogle Scholar
  • 46 Condat B, Pessione F, Helene D M, Hillaire S, Valla D. Recent portal or mesenteric venous thrombosis: increased recognition and frequent recanalization on anticoagulant therapy.  Hepatology. 2000;  32(3) 466-470
    CrossrefPubMedGoogle Scholar
  • 47 Baril N, Wren S, Radin R, Ralls P, Stain S. The role of anticoagulation in pylephlebitis.  Am J Surg. 1996;  172(5) 449-452
    CrossrefPubMedGoogle Scholar
  • 48 Amitrano L, Guardascione M A, Scaglione M et al.. Prognostic factors in noncirrhotic patients with splanchnic vein thromboses.  Am J Gastroenterol. 2007;  102(11) 2464-2470
    CrossrefPubMedGoogle Scholar
  • 49 Lopera J E, Correa G, Brazzini A et al.. Percutaneous transhepatic treatment of symptomatic mesenteric venous thrombosis.  J Vasc Surg. 2002;  36(5) 1058-1061
    CrossrefPubMedGoogle Scholar
  • 50 Aytekin C, Boyvat F, Kurt A, Yologlu Z, Coskun M. Catheter-directed thrombolysis with transjugular access in portal vein thrombosis secondary to pancreatitis.  Eur J Radiol. 2001;  39(2) 80-82
    CrossrefPubMedGoogle Scholar
  • 51 Hollingshead M, Burke C T, Mauro M A, Weeks S M, Dixon R G, Jaques P F. Transcatheter thrombolytic therapy for acute mesenteric and portal vein thrombosis.  J Vasc Interv Radiol. 2005;  16(5) 651-661
    CrossrefPubMedGoogle Scholar
  • 52 Leebeek F W, Lameris J S, van Buuren H R, Gomez E, Madretsma S, Sonneveld P. Budd-Chiari syndrome, portal vein and mesenteric vein thrombosis in a patient homozygous for factor V Leiden mutation treated by TIPS and thrombolysis.  Br J Haematol. 1998;  102(4) 929-931
    CrossrefPubMedGoogle Scholar
  • 53 Pfammatter T, Benoit C, Cathomas G, Blum U. Budd-Chiari syndrome with spleno-mesenteric-portal thrombosis: treatment with extended TIPS.  J Vasc Interv Radiol. 2000;  11(6) 781-784
    CrossrefPubMedGoogle Scholar
  • 54 Senzolo M, Cholongitas E, Davies N et al.. Transjugular intrahepatic portosystemic shunt (TIPS), the preferred therapeutic option for Budd Chiari syndrome associated with portal vein thrombosis.  Am J Gastroenterol. 2006;  101(9) 2163-2164
    PubMedGoogle Scholar
  • 55 Dolovich L R, Ginsberg J S, Douketis J D, Holbrook A M, Cheah G. A meta-analysis comparing low-molecular-weight heparins with unfractionated heparin in the treatment of venous thromboembolism: examining some unanswered questions regarding location of treatment, product type, and dosing frequency.  Arch Intern Med. 2000;  160(2) 181-188
    CrossrefPubMedGoogle Scholar
  • 56 Plemmons R M, Dooley D P, Longfield R N. Septic thrombophlebitis of the portal vein (pylephlebitis): diagnosis and management in the modern era.  Clin Infect Dis. 1995;  21(5) 1114-1120
    CrossrefPubMedGoogle Scholar
  • 57 Ganguly S, Sarin S K, Bhatia V, Lahoti D. The prevalence and spectrum of colonic lesions in patients with cirrhotic and noncirrhotic portal hypertension.  Hepatology. 1995;  21(5) 1226-1231
    CrossrefPubMedGoogle Scholar
  • 58 Chawla Y, Dilawari J B. Anorectal varices–their frequency in cirrhotic and non-cirrhotic portal hypertension.  Gut. 1991;  32(3) 309-311
    CrossrefPubMedGoogle Scholar
  • 59 Chawla Y, Dilawari J B, Katariya S. Gallbladder varices in portal vein thrombosis.  AJR Am J Roentgenol. 1994;  162(3) 643-645
    PubMedGoogle Scholar
  • 60 Alvarez F, Bernard O, Brunelle F, Hadchouel P, Odievre M, Alagille D. Portal obstruction in children. I. Clinical investigation and hemorrhage risk.  J Pediatr. 1983;  103(5) 696-702
    PubMedGoogle Scholar
  • 61 Merkel C, Bolognesi M, Bellon S et al.. Long-term follow-up study of adult patients with non-cirrhotic obstruction of the portal system: comparison with cirrhotic patients.  J Hepatol. 1992;  15(3) 299-303
    CrossrefPubMedGoogle Scholar
  • 62 Condat B, Pessione F, Hillaire S et al.. Current outcome of portal vein thrombosis in adults: risk and benefit of anticoagulant therapy.  Gastroenterology. 2001;  120(2) 490-497
    CrossrefPubMedGoogle Scholar
  • 63 Dilawari J B, Chawla Y K. Pseudosclerosing cholangitis in extrahepatic portal venous obstruction.  Gut. 1992;  33(2) 272-276
    PubMedGoogle Scholar
  • 64 Khuroo M S, Yattoo G N, Zargar S A et al.. Biliary abnormalities associated with extrahepatic portal venous obstruction.  Hepatology. 1993;  17(5) 807-813
    CrossrefPubMedGoogle Scholar
  • 65 Dhiman R K, Puri P, Chawla Y et al.. Biliary changes in extrahepatic portal venous obstruction: compression by collaterals or ischemic?.  Gastrointest Endosc. 1999;  50(5) 646-652
    CrossrefPubMedGoogle Scholar
  • 66 Condat B, Vilgrain V, Asselah T et al.. Portal cavernoma-associated cholangiopathy: a clinical and MR cholangiography coupled with MR portography imaging study.  Hepatology. 2003;  37(6) 1302-1308
    CrossrefPubMedGoogle Scholar
  • 67 Malkan G H, Bhatia S J, Bashir K et al.. Cholangiopathy associated with portal hypertension: diagnostic evaluation and clinical implications.  Gastrointest Endosc. 1999;  49(3 Pt 1) 344-348
    CrossrefPubMedGoogle Scholar
  • 68 Gauthier-Villars M, Franchi S, Gauthier F, Fabre M, Pariente D, Bernard O. Cholestasis in children with portal vein obstruction.  J Pediatr. 2005;  146(4) 568-573
    PubMedGoogle Scholar
  • 69 Sezgin O, Oguz D, Altintas E, Saritas U, Sahin B. Endoscopic management of biliary obstruction caused by cavernous transformation of the portal vein.  Gastrointest Endosc. 2003;  58(4) 602-608
    CrossrefPubMedGoogle Scholar
  • 70 Mitra S K, Kumar V, Datta D V et al.. Extrahepatic portal hypertension: a review of 70 cases.  J Pediatr Surg. 1978;  13(1) 51-57
    CrossrefPubMedGoogle Scholar
  • 71 Cohen J, Edelman R R, Chopra S. Portal vein thrombosis: a review.  Am J Med. 1992;  92(2) 173-182
    CrossrefPubMedGoogle Scholar
  • 72 Sarin S K, Bansal A, Sasan S, Nigam A. Portal-vein obstruction in children leads to growth retardation.  Hepatology. 1992;  15(2) 229-233
    CrossrefPubMedGoogle Scholar
  • 73 Rangari M, Gupta R, Jain M, Malhotra V, Sarin S K. Hepatic dysfunction in patients with extrahepatic portal venous obstruction.  Liver Int. 2003;  23(6) 434-439
    CrossrefPubMedGoogle Scholar
  • 74 Webb L J, Sherlock S. The aetiology, presentation and natural history of extra-hepatic portal venous obstruction.  Q J Med. 1979;  48(192) 627-639
    PubMedGoogle Scholar
  • 75 Minguez B, Garcia-Pagan J C, Bosch J et al.. Noncirrhotic portal vein thrombosis exhibits neuropsychological and MR changes consistent with minimal hepatic encephalopathy.  Hepatology. 2006;  43(4) 707-714
    CrossrefPubMedGoogle Scholar
  • 76 Mack C L, Zelko F A, Lokar J et al.. Surgically restoring portal blood flow to the liver in children with primary extrahepatic portal vein thrombosis improves fluid neurocognitive ability.  Pediatrics. 2006;  117(3) e405-e412
    CrossrefPubMedGoogle Scholar
  • 77 Groeneweg M, Quero J C, De Bruijn I et al.. Subclinical hepatic encephalopathy impairs daily functioning.  Hepatology. 1998;  28(1) 45-49
    CrossrefPubMedGoogle Scholar
  • 78 Dubuisson C, Boyer-Neumann C, Wolf M, Meyer D, Bernard O. Protein C, protein S and antithrombin III in children with portal vein obstruction.  J Hepatol. 1997;  27(1) 132-135
    CrossrefPubMedGoogle Scholar
  • 79 Kobayashi S, Ng C S, Kazama T et al.. Hemodynamic and morphologic changes after portal vein embolization: differential effects in central and peripheral zones in the liver on multiphasic computed tomography.  J Comput Assist Tomogr. 2004;  28(6) 804-810
    CrossrefPubMedGoogle Scholar
  • 80 Vilgrain V, Condat B, Bureau C et al.. Atrophy-hypertrophy complex in patients with cavernous transformation of the portal vein: CT evaluation.  Radiology. 2006;  241(1) 149-155
    CrossrefPubMedGoogle Scholar
  • 81 Bilodeau M, Aubry M C, Houle R, Burnes P N, Ethier C. Evaluation of hepatocyte injury following partial ligation of the left portal vein.  J Hepatol. 1999;  30(1) 29-37
    CrossrefPubMedGoogle Scholar
  • 82 Mack C L, Superina R A, Whitington P F. Surgical restoration of portal flow corrects procoagulant and anticoagulant deficiencies associated with extrahepatic portal vein thrombosis.  J Pediatr. 2003;  142(2) 197-199
    CrossrefPubMedGoogle Scholar
  • 83 De Gaetano A M, LaFortune M, Patriquin H, De F A, Aubin B, Paradis K. Cavernous transformation of the portal vein: patterns of intrahepatic and splanchnic collateral circulation detected with Doppler sonography.  AJR Am J Roentgenol. 1995;  165(5) 1151-1155
    PubMedGoogle Scholar
  • 84 Ueno N, Sasaki A, Tomiyama T, Tano S, Kimura K. Color Doppler ultrasonography in the diagnosis of cavernous transformation of the portal vein.  J Clin Ultrasound. 1997;  25(5) 227-233
    CrossrefPubMedGoogle Scholar
  • 85 Lai L, Brugge W R. Endoscopic ultrasound is a sensitive and specific test to diagnose portal venous system thrombosis (PVST).  Am J Gastroenterol. 2004;  99(1) 40-44
    CrossrefPubMedGoogle Scholar
  • 86 Palazzo L, Hochain P, Helmer C et al.. Biliary varices on endoscopic ultrasonography: clinical presentation and outcome.  Endoscopy. 2000;  32(7) 520-524
    Article in Thieme ConnectPubMedGoogle Scholar
  • 87 Umphress J L, Pecha R E, Urayama S. Biliary stricture caused by portal biliopathy: diagnosis by EUS with Doppler US.  Gastrointest Endosc. 2004;  60(6) 1021-1024
    CrossrefPubMedGoogle Scholar
  • 88 Francoz C, Belghiti J, Vilgrain V et al.. Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation.  Gut. 2005;  54(5) 691-697
    CrossrefPubMedGoogle Scholar
  • 89 Spaander C W, Murad S D, van Buuren H R, Hansen B E, Kuipers E J, Janssen H L. Endoscopic treatment of esophagogastric variceal bleeding in patients with noncirrhotic extrahepatic portal vein thrombosis: a long-term follow-up study.  Gastrointest Endosc. 2008;  67(6) 821-827
    CrossrefPubMedGoogle Scholar
  • 90 Condat B, Valla D. Nonmalignant portal vein thrombosis in adults.  Nat Clin Pract Gastroenterol Hepatol. 2006;  3(9) 505-515
    CrossrefPubMedGoogle Scholar
  • 91 Sarin S K, Sachdev G, Nanda R. Follow-up of patients after variceal eradication. A comparison of patients with cirrhosis, noncirrhotic portal fibrosis, and extrahepatic obstruction.  Ann Surg. 1986;  204(1) 78-82
    PubMedGoogle Scholar
  • 92 Chawla Y K, Dilawari J B, Ramesh G N, Kaur U, Mitra S K, Walia B N. Sclerotherapy in extrahepatic portal venous obstruction.  Gut. 1990;  31(2) 213-216
    CrossrefPubMedGoogle Scholar
  • 93 Vleggaar F P, van Buuren H R, Schalm S W. Endoscopic sclerotherapy for bleeding oesophagogastric varices secondary to extrahepatic portal vein obstruction in an adult Caucasian population.  Eur J Gastroenterol Hepatol. 1998;  10(1) 81-85
    PubMedGoogle Scholar
  • 94 Zargar S A, Javid G, Khan B A et al.. Endoscopic ligation compared with sclerotherapy for bleeding esophageal varices in children with extrahepatic portal venous obstruction.  Hepatology. 2002;  36(3) 666-672
    CrossrefPubMedGoogle Scholar
  • 95 Zargar S A, Javid G, Khan B A et al.. Endoscopic ligation vs. sclerotherapy in adults with extrahepatic portal venous obstruction: a prospective randomized study.  Gastrointest Endosc. 2005;  61(1) 58-66
    CrossrefPubMedGoogle Scholar
  • 96 Orr D W, Harrison P M, Devlin J et al.. Chronic mesenteric venous thrombosis: evaluation and determinants of survival during long-term follow-up.  Clin Gastroenterol Hepatol. 2007;  5(1) 80-86
    CrossrefPubMedGoogle Scholar
  • 97 Warren W D, Henderson J M, Millikan W J, Galambos J T, Bryan F C. Management of variceal bleeding in patients with noncirrhotic portal vein thrombosis.  Ann Surg. 1988;  207(5) 623-634
    PubMedGoogle Scholar
  • 98 Orloff M J, Orloff M S, Girard B, Orloff S L. Bleeding esophagogastric varices from extrahepatic portal hypertension: 40 years' experience with portal-systemic shunt.  J Am Coll Surg. 2002;  194(6) 717-728
    CrossrefPubMedGoogle Scholar
  • 99 de Ville de Goyet J, Alberti D, Clapuyt P et al.. Direct bypassing of extrahepatic portal venous obstruction in children: a new technique for combined hepatic portal revascularization and treatment of extrahepatic portal hypertension.  J Pediatr Surg. 1998;  33(4) 597-601
    CrossrefPubMedGoogle Scholar
  • 100 Radosevich P M, Ring E J, LaBerge J M et al.. Transjugular intrahepatic portosystemic shunts in patients with portal vein occlusion.  Radiology. 1993;  186(2) 523-527
    PubMedGoogle Scholar
  • 101 Cwikiel W, Keussen I, Larsson L, Solvig J, Kullendorff C M. Interventional treatment of children with portal hypertension secondary to portal vein occlusion.  Eur J Pediatr Surg. 2003;  13(5) 312-318
    Article in Thieme ConnectPubMedGoogle Scholar
  • 102 Bilbao J I, Elorz M, Vivas I, Martinez-Cuesta A, Bastarrika G, Benito A. Transjugular intrahepatic portosystemic shunt (TIPS) in the treatment of venous symptomatic chronic portal thrombosis in non-cirrhotic patients.  Cardiovasc Intervent Radiol. 2004;  27(5) 474-480
    PubMedGoogle Scholar
  • 103 Senzolo M, Patch D, Cholongitas E, Burroughs A K. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with and without underlying cirrhosis.  Cardiovasc Intervent Radiol. 2007;  30(3) 545
    CrossrefPubMedGoogle Scholar
  • 104 Thervet L, Faulques B, Pissas A et al.. Endoscopic management of obstructive jaundice due to portal cavernoma.  Endoscopy. 1993;  25(6) 423-425
    PubMedGoogle Scholar
  • 105 Bhatia V, Jain A K, Sarin S K. Choledocholithiasis associated with portal biliopathy in patients with extrahepatic portal vein obstruction: management with endoscopic sphincterotomy.  Gastrointest Endosc. 1995;  42(2) 178-181
    CrossrefPubMedGoogle Scholar
  • 106 Tighe M, Jacobson I. Bleeding from bile duct varices: an unexpected hazard during therapeutic ERCP.  Gastrointest Endosc. 1996;  43(3) 250-252
    CrossrefPubMedGoogle Scholar
  • 107 Mutignani M, Shah S K, Bruni A, Perri V, Costamagna G. Endoscopic treatment of extrahepatic bile duct strictures in patients with portal biliopathy carries a high risk of haemobilia: report of 3 cases.  Dig Liver Dis. 2002;  34(8) 587-591
    CrossrefPubMedGoogle Scholar
  • 108 Vibert E, Azoulay D, Aloia T et al.. Therapeutic strategies in symptomatic portal biliopathy.  Ann Surg. 2007;  246(1) 97-104
    CrossrefPubMedGoogle Scholar
  • 109 Dhiman R K, Behera A, Chawla Y K, Dilawari J B, Suri S. Portal hypertensive biliopathy.  Gut. 2007;  56(7) 1001-1008
    CrossrefPubMedGoogle Scholar
  • 110 Chaudhary A, Dhar P, Sarin S K et al.. Bile duct obstruction due to portal biliopathy in extrahepatic portal hypertension: surgical management.  Br J Surg. 1998;  85(3) 326-329
    CrossrefPubMedGoogle Scholar
  • 111 Hajdu C H, Murakami T, Diflo T et al.. Intrahepatic portal cavernoma as an indication for liver transplantation.  Liver Transpl. 2007;  13(9) 1312-1316
    CrossrefPubMedGoogle Scholar
  • 112 Sogaard K K, Astrup L B, Vilstrup H, Gronbaek H. Portal vein thrombosis; risk factors, clinical presentation and treatment.  BMC Gastroenterol. 2007;  7 34
    CrossrefPubMedGoogle Scholar
  • 113 Ogren M, Bergqvist D, Bjorck M, Acosta S, Eriksson H, Sternby N H. Portal vein thrombosis: prevalence, patient characteristics and lifetime risk: a population study based on 23,796 consecutive autopsies.  World J Gastroenterol. 2006;  12(13) 2115-2119
    CrossrefPubMedGoogle Scholar

Juan Carlos Garcia-PagánM.D. 

Hepatic Hemodynamic Laboratory, Liver Unit, Hospital Clínic

Villarroel 170, Barcelona 08036, Spain

Email: jcgarcia@clinic.ub.es

      >